This content is from: Premium
Activist Hedge Funds Are Having More Trouble Stopping Deals
Starboard, Pershing Square, Third Point and Icahn have all failed to stop M&A transactions they oppose, a new report notes.
Several big-name activists have been unsuccessful in shaping the corporate landscape by stopping mergers they oppose, a new report details.Starboard Value couldn’t stop Bristol-Myers Squibb from taking over Celgene, and neither Pershing Square Capital Management nor Third Point had any success in stopping United Technologies from its plans to acquire
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.